Episode 19: LEAD Trial for Use of Nanopulse Laser for Dry AMD with Dr. Robyn Guymer

Keyvan Koushan, MD, FRCSC

Audio
Published 2018

clinical trials, dry AMD (non-neovascular), age-related macular degeneration, lasers, retinal pigment epithelium, geographic atrophy, drusen, clinical trials, delivery devices

Avacincaptad Pegol, A Novel C5 Inhibitor, Demonstrates Continued Reduction in Geographic Atrophy Growth: 18-Month Results From GATHER1 Clinical Trial
Jason Hsu, MD
Annual Meeting Talks
2021
Characterizing Real-World Functional Outcomes in Patients with Geographic Atrophy: An IRIS Registry Analysis
Durga Borkar, MD
Annual Meeting Talks
2022
Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2022

Category: AMD-Non-Neovascular

Retinal Pigment Epithelium
Geographic Atrophy
age-related macular degeneration (AMD)
The Retina Channel
drug delivery devices
clinical trials
Lasers
Dry AMD

See more

Member Podcasts
Keyvan Koushan, MD, FRCSC

Sign in to view content

Episode 19: LEAD Trial for Use of Nanopulse Laser for Dry AMD with Dr. Robyn Guymer

Related

See more